Cleared Traditional

K964239 - COMBINATION OXIMETER/CARBON DIOXIDE GAS ANALYZER

K964239 is an FDA 510(k) clearance for COMBINATION OXIMETER/CARBON DIOXIDE GAS..., manufactured by Spegas Industries, Ltd.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 198-day FDA review.

K964239 · Spegas Industries, Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1997
Decision
198d
Days
Class 2
Risk

K964239 is an FDA 510(k) clearance for the COMBINATION OXIMETER/CARBON DIOXIDE GAS ANALYZER. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Spegas Industries, Ltd. (Wellesley, US). The FDA issued a Cleared decision on May 9, 1997 after a review of 198 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Spegas Industries, Ltd. devices

FDA 510(k) Submission Details - K964239

510(k) Number K964239 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 23, 1996
Decision Date May 09, 1997
Days to Decision 198 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d slower than avg
Panel avg: 140d · This submission: 198d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 230
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K964239.
RAC 2A MODULE HOUSING
K973984 · Marquette Medical Systems, Inc. · Jan 1998
CAPNOXYGEN MASK
K971229 · Medsys, Inc. · Sep 1997
MODEL 405T WITH ETCO2 OPTION
K964961 · Ivy Biomedical Systems, Inc. · May 1997
CAPNOCHECK PLUS
K970209 · Bci Intl., Inc. · Apr 1997
TONOCAP, TC-200 AND ACCESSORY CATHETERS
K962638 · Instrumentarium Corp. · Apr 1997
MODEL 9500 MR-COMPATIBLE MULTIGAS MONITOR
K954120 · Magnetic Resonance Equipment Corp. · Apr 1997